Asthma: is there an airway receptor barrier?

Hills, B. A.
August 1996
Thorax;Aug1996, Vol. 51 Issue 8, p773
Academic Journal
No abstract available.


Related Articles

  • Apoptosis-Regulatory Factors as Potential Drug Targets in the Epithelium of Normal and Inflamed Airways. Zalewski, P. D.; Ruffin, R. E. // Current Molecular Pharmacology;Jan2008, Vol. 1 Issue 1, p38 

    Airway epithelium (AE) lines the conducting airways of the respiratory system and functions to maintain airway integrity by providing both a physical barrier to inhaled noxious agents and a mechanism for their clearance via the mucociliary escalator. Normal AE cells are relatively refractory to...

  • A promising approach for asthma treatment by multiwayly modulating toll-like receptors. H.-T. XIAO; Z. LIAO; L. CHEN; R.-S. TONG // European Review for Medical & Pharmacological Sciences;2012, Vol. 16 Issue 15, p2088 

    Asthma is a major epidemic affecting up to one third people in developed countries over the last decades, and making a crucial impact on morbidity rates. The classical characters of asthma in human are airway inflammation, airway hyperreactivity, and airway remodeling. Hygiene hypothesis,...

  • Leukotriene-receptor antagonists and related compounds.  // CMAJ: Canadian Medical Association Journal;11/30/99 Supplement, Vol. 161, pS31 

    The article focuses on the role of cysteinyl leukotriene-receptor antagonists (LTRA) in the treatment of asthma. Cysteinel LTRA, which can be considered as an alternative to inhaled glucocorticosteroids, acts as biochemical mediators in asthma. They act on human airway obstruction. The studies...

  • TLR4 signalling in pulmonary stromal cells is critical for inflammation and immunity in the airways. Perros, Frederic; Lambrecht, Bart N.; Hammad, Hamida // Respiratory Research;Sep2011, Vol. 12 Issue 9, p1 

    Inflammation of the airways, which is often associated with life-threatening infection by Gram-negative bacteria or presence of endotoxin in the bioaerosol, is still a major cause of severe airway diseases. Moreover, inhaled endotoxin may play an important role in the development and progression...

  • Oxidant-induced corticosteroid unresponsiveness in human bronchial epithelial cells. Heijink, Irene; van Oosterhout, Antoon; Kliphuis, Nathalie; Jonker, Marnix; Hoffmann, Roland; Telenga, Eef; Klooster, Karin; Slebos, Dirk-Jan; Hacken, Nick ten; Postma, Dirkje; van den Berge, Maarten // Thorax;Jan2014, Vol. 69 Issue 1, p5 

    Background We hypothesised that increased oxidative stress, as present in the airways of asthma and chronic obstructive pulmonary disease (COPD) patients, induces epithelial damage and reduces epithelial responsiveness to suppressive effects of corticosteroids on proinflammatory cytokine...

  • Airway Remodeling: Effect of Current and Future Asthma Therapies. Burgess, Janette K.; Moir, Lyn M. // Current Respiratory Medicine Reviews;2007, Vol. 3 Issue 4, p297 

    Airway remodeling (the structural changes which occur in the airways) is one of the characteristic features of severe persistent asthma. These changes include thickening of the laminar reticularis, an increase in the bulk of the airway smooth muscle, thickening of the basement membrane and...

  • Bitter treats for better breathing. Sanderson, Michael J.; Madison, J. Mark // Nature Medicine;Nov2010, Vol. 16 Issue 11, p1190 

    The article offers information on the new study in mice and human tissue regarding the activation of bitter taste receptors in the airways which relaxes airway smooth muscle for better breathing. It states that airway hyperresponsiveness is a key characteristic of asthma, which results from...

  • Zafirlukast.  // AHFS Consumer Medication Information;Oct2017, p1 

    Zafirlukast is used to prevent asthma symptoms. Zafirlukast is in a class of medications called leukotriene receptor antagonists (LTRAs). It works by blocking the action of certain natural substances that cause swelling and tightening of the airways.

  • AHR in asthma. Primhak, R. A.; Powell, C. V. E. // Thorax;Feb2002, Vol. 57 Issue 2, p186 

    Presents a letter to the editor, on airway hyperresponsiveness in asthma.

  • Inhibition of CD23-mediated IgE transcytosis suppresses the initiation and development of allergic airway inflammation. Palaniyandi, S; Liu, X; Periasamy, S; Ma, A; Tang, J; Jenkins, M; Tuo, W; Song, W; Keegan, A D; Conrad, D H; Zhu, X // Mucosal Immunology (1933-0219);Nov2015, Vol. 8 Issue 6, p1262 

    The epithelial lining of the airway tract and allergen-specific IgE are considered essential controllers of inflammatory responses to allergens. The human low affinity IgE receptor, CD23 (FcɛRII), is capable of transporting IgE or IgE-allergen complexes across the polarized human airway...


Read the Article


Sign out of this library

Other Topics